Monitor for any strategic shifts under new Chairman Conroy, but this is a standard governance transition with no immediate trading implications.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 22 $173.76entry
- T+1 · 5mo ago −3.03%α −1.58% · $168.49
- T+5 · 5mo ago +2.69%α +4.76% · $178.43
- T+20 · 4mo ago +1.73%α +1.87% · $176.76
- T+60 · 2mo ago −15.40%α −17.15% · $147.00
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Align Technology announced the planned retirement of Chairman C. Raymond Larkin, Jr., effective July 1, 2026 as Chairman and December 31, 2026 from the Board, with independent director Kevin Conroy appointed as Chairman effective July 1, 2026. This is a routine board leadership transition with no disagreement or cause cited, and Conroy brings relevant healthcare and governance experience from his prior CEO role at Exact Sciences.
Key Facts
- Chairman C. Raymond Larkin, Jr. will retire as Chairman effective July 1, 2026 and from the Board effective December 31, 2026.
- Kevin Conroy, an independent director since December 2023, appointed Chairman effective July 1, 2026.
- Larkin's departure is not due to any disagreement with the company or removal for cause.
- Conroy previously served as Chairman and CEO of Exact Sciences Corp. until its acquisition by Abbott Laboratories in March 2026.
Financial Impact
No financial impact, routine board succession with no material financial terms disclosed.
Risk Factors
- Potential loss of institutional knowledge with Larkin's departure after 20+ years on the board.
- No material risk, transition is orderly and planned.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001097149-26-000048 |
| Document: algn-ex991algnpressrelease.htm | 0001097149-26-000048 |
| Document: 0001097149-26-000048-index-headers.html | 0001097149-26-000048 |
| Document: 0001097149-26-000048-index.html | 0001097149-26-000048 |
| Document: 0001097149-26-000048.txt | 0001097149-26-000048 |
Track record
19 reports on ALGN
4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +12.30% at T+60 after the Aug 3, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $168.32 Now $168.32 +0.00% settles Dec 14
- Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $172.08 Now $168.32 −2.19% settles Dec 10
- Nov 5, 202610d ago 8-K Neutral 4/10 Entry $166.00 Now $168.32 +1.40% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $159.37 Now $168.32 +5.62% settles Dec 4
- Nov 2, 202614d ago 3 Neutral 1/10 Entry $151.58 Now $168.32 +11.04% settles Dec 2
- Oct 28, 202619d ago 8-K Neutral 3/10 Entry $153.71 Now $168.32 +9.50% settles Nov 27
- Oct 28, 202619d ago 8-K Neutral 5/10 Entry $153.71 Now $168.32 +9.50% settles Nov 27
- Oct 21, 202627d ago PTAB Trial Mixed 6/10 Entry $155.51 Now $168.32 +8.24% settles Nov 19
- Oct 16, 20264w ago Institutional Cluster Bearish 4/10 Entry $148.90 to $165.98 Now $168.32 −13.04% ▼ −11.47% −14.93% vs SPY
- Aug 31, 202611w ago 8-K Neutral 2/10 Entry $154.96 to $145.35 Now $168.32 +8.62% ▼ −6.20% −6.52% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers